Prof. Dr. EMİRE SEYAHİ

Yayın Ağı

Makaleler 183

1. Internal carotid artery involvement and stroke risk in Takayasu arteritis: a case–control study

Bukun H. O., UYGUNOĞLU U., Senturk E. F., Duru G., KIZILKILIÇ O., ESATOĞLU S. N., et al.

Rheumatology International , cilt.46, sa.3, 2026 (SCI-Expanded, Scopus)

2. Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet’s syndrome

Fidan S., ESATOĞLU S. N., ÖZGÜLER Y., UĞURLU S., SEYAHİ E., MELİKOĞLU M., et al.

Rheumatology , cilt.65, sa.2, 2026 (SCI-Expanded, Scopus)

3. Cardiac Manifestations in Behçet’s Syndrome

Bello F., Bagni G., SEYAHİ E., Chiara E., Olivotto I., Saadoun D., et al.

Current Rheumatology Reports , cilt.27, sa.1, 2025 (SCI-Expanded, Scopus)

4. Arterial and venous thrombosis in systemic and monogenic vasculitis

Bello F., Fagni F., Bagni G., Hill C. L., Mohammad A. J., Moiseev S., et al.

Nature Reviews Rheumatology , cilt.21, sa.6, ss.355-369, 2025 (SCI-Expanded, Scopus)

5. De novo manifestations during adalimumab treatment in Behçet's syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.

RHEUMATOLOGY , cilt.64, sa.4, ss.2034-2040, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Targeting complement dysregulation: eculizumab in scleroderma renal crisis management-a case-based review

TOKER DİNÇER Z., DİNÇER M. T., Sen G., UĞURLU S., SEYAHİ N., SEYAHİ E.

RHEUMATOLOGY INTERNATIONAL , cilt.44, sa.12, ss.3135-3140, 2024 (SCI-Expanded, Scopus)

7. Pulmonary artery involvement due to Behçet's syndrome and Hughes Stovin syndrome: a comparative study.

Ordu B., ASLAN M. Ç., ÖZGÜLER Y., Durmaz E. Ş., Melikoglu M., FRESKO İ., et al.

Clinical and experimental rheumatology , cilt.42, sa.10, ss.2021-2031, 2024 (SCI-Expanded, Scopus)

8. HLA-B gene methylation and expression in Behçet's syndrome: a potential role of epigenetics in the pathogenesis

Onen M. O., Everest E., Demirci T., Sen P. K., Kisakesen E. K., Ozguler Y., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.10, ss.2014-2020, 2024 (SCI-Expanded, Scopus)

9. Tocilizumab may not be a good option for vascular involvement due to Behçet's syndrome.

Ozdede A., ESATOĞLU S. N., Durmaz E. Ş., Karakoc A., Ogun H., HATEMİ G., et al.

Clinical and experimental rheumatology , cilt.42, sa.10, ss.2057-2064, 2024 (SCI-Expanded, Scopus)

10. Behçet’s syndrome: one year in review 2024

Hatemi G., Seyahi E., Fresko İ., Talarico R., Uçar D., Hamuryudan V.

Clinical and Experimental Rheumatology , cilt.42, sa.10, ss.1999-2007, 2024 (SCI-Expanded, Scopus)

11. Atrial myxoma as a mimicker of intracardiac thrombus in Behcet's syndrome: a case study with histopathological confirmation

Ak T., Bayrakdar B., BATUR Ş., Durmaz E. S., Cimci M., SEYAHİ E.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.42, sa.10, ss.2092-2095, 2024 (SCI-Expanded, Scopus)

12. Role of Optical Coherence Tomography in Vasculitis-Associated Pulmonary Hypertension and Chronic Thromboembolic Pulmonary Hypertension.

Avci B., SEYAHİ E., Polat F., Kolak Z., Yalman H., ATAHAN E., et al.

Circulation journal : official journal of the Japanese Circulation Society , cilt.88, sa.10, ss.1620-1628, 2024 (SCI-Expanded, Scopus)

13. Folliculitis might be associated with pathergy-positivity in patients with Behçet syndrome.

Altan Ferhatoǧlu Z., Altinişik D. D., Özdede A., Özkoca D., Güner S., Yildiz K. A., et al.

Medicine , cilt.103, sa.12, 2024 (SCI-Expanded, Scopus)

14. A Proposal of a New Tool for the Assessment of Damage in Behçet Syndrome Uveitis: Cerrahpasa Ocular Damage Grading System

Ozyazgan Y., UÇAR D., BATU OTO B., ESATOĞLU S. N., ÖZGÜLER Y., HATEMİ G., et al.

Ocular Immunology and Inflammation , cilt.32, sa.10, ss.2332-2338, 2024 (SCI-Expanded, Scopus)

15. Prevalance and risk factors of thromboembolism in Inflammatory Bowel Disease

Kati O., Bakkaloglu O. K., Hatemi I., Celik A. F., SEYAHİ E., Erzin Y.

JOURNAL OF CROHNS & COLITIS , 2024 (SCI-Expanded, Scopus)

16. Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis

UÇAR D., ESATOĞLU S. N., Cerme E., BATU OTO B., Hamuryudan V., SEYAHİ E., et al.

Rheumatology International , cilt.43, sa.11, ss.2099-2106, 2023 (SCI-Expanded, Scopus)

17. Intravenous immunoglobulin and rituximab in a treatment-refractory COVID-19-associated central nervous system vasculitis: A case report and literature review

Mutlu O. A., İriş M., Erener N., KIZILKILIÇ O., Işlak C., SEYAHİ E., et al.

Clinical and Experimental Neuroimmunology , cilt.14, sa.4, ss.195-201, 2023 (Scopus)

18. De Novo Manifestations During Adalimumab Treatment in Behcet Syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3070-3072, 2023 (SCI-Expanded, Scopus)

19. Behçet's syndrome: one year in review 2023

Hatemi G., SEYAHİ E., Fresko I., Talarico R., Ucar D., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.41, sa.10, ss.1945-1954, 2023 (SCI-Expanded, Scopus)

20. Abdominal aortic aneurysm healed with calcification in a female patient with Behçet's syndrome: A case report with a 2-decade follow-up

Tuzun H., Ak T., Baş A., Kara O., Gülşen F., Seyahi E.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.0, 2023 (SCI-Expanded, Scopus)

21. Sistemik lupus eritematozusda plazma değişim tedavisi: Tek merkez retrospektif kohort çalışması

Özgüler Y., Ak T., Esatoğlu S. N., Elverdi T., Eşkazan A. E., Uğurlu S., et al.

Ulusal Romatoloji Dergisi , cilt.15, sa.2, ss.89-94, 2023 (TRDizin)

22. INCREASED ARTERIAL STIFFNESS AND ACCELERATED ATHEROSCLEROSIS IN TAKAYASU ARTERITIS

KALYONCU UÇAR A., Ozdede A., Kayadibi Y., Adaletli I., Melikoglu M., Fresko I., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.638-639, 2023 (SCI-Expanded, Scopus)

23. TOCILIZUMAB TREATMENT IN SEVERE AND REFRACTORY BEHCET'S SYNDROME: A CASE SERIES

Dincer Z. T., Yurttas B., Esatoglu S. N., Ucar D., Uygunoglu U., UĞURLU S., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.1571, 2023 (SCI-Expanded, Scopus)

24. Increased arterial stiffness and accelerated atherosclerosis in Takayasu arteritis

Ucar A., Ozdede A., Kayadibi Y., Adaletli İ., Melikoglu M., Fresko I., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.60, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Juvenile and adult-onset scleroderma: Different clinical phenotypes.

Adrovic A., Karatemiz G., Esatoglu S. N., Yildiz M., Sahin S., Barut K., et al.

Seminars in arthritis and rheumatism , cilt.60, ss.152197, 2023 (SCI-Expanded, Scopus)

26. Behçet disease, familial Mediterranean fever and MEFV variations: More than just an association.

Seyahi E., Ugurlu S., Amikishiyev S., Gul A.

Clinical immunology (Orlando, Fla.) , cilt.251, ss.109630, 2023 (SCI-Expanded, Scopus)

27. Secukinumab-induced IgA vasculitis in a patient with psoriatic arthritis

Ak T., Özince R. B., Erzin Y. Z., Melikoğlu M., Seyahi E.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.00, sa.00, 2023 (SCI-Expanded, Scopus)

28. Vascular Behçet syndrome: from pathogenesis to treatment.

Bettiol A., Alibaz-Oner F., Direskeneli H., Hatemi G., Saadoun D., Seyahi E., et al.

Nature reviews. Rheumatology , cilt.19, sa.2, ss.111-126, 2023 (SCI-Expanded, Scopus)

29. Orbital Mass as the Only Presenting Sign with Overlapping Features of Lupus Erythematosus Panniculitis and Subcutaneous Panniculitis-Like T-Cell Lymphoma

Mangan M. S., Sarici A. M., Yalcin O., Aydin D., Yegen G., Seyahi E.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.31, sa.4, ss.717-720, 2023 (SCI-Expanded, Scopus)

30. Frequency of AA amyloidosis has decreased in Behcet's syndrome: a retrospective study with long-term follow-up and a systematic review Amyloidosis in Behcet's syndrome

Karatemiz G., ESATOĞLU S. N., Gurcan M., ÖZGÜLER Y., YURDAKUL S., HAMURYUDAN V., et al.

RHEUMATOLOGY , cilt.62, sa.1, ss.9-18, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Behcet's syndrome: one year in review 2022

Hatemi G., SEYAHİ E., Fresko I., Talarico R., Ucar D., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.40, sa.8, ss.1461-1471, 2022 (SCI-Expanded, Scopus)

32. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine

ÖZTAŞ M., BEKTAŞ M., KARACAN İ., Aliyeva N., DAĞ A., Aghamuradov S., et al.

JOURNAL OF MEDICAL VIROLOGY , cilt.94, sa.7, ss.3431-3437, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine

Ozdede A., GÜNER S., Ozcifci G., YURTTAŞ B., TOKER DİNCER Z., Atli Z., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.42, ss.973-987, 2022 (SCI-Expanded, Scopus)

34. FREQUENCY AND SEVERITY OF COVID-19 IN PATIENTS WITH VARIOUS RHEUMATIC DISEASES TREATED REGULARLY WITH COLCHICINE OR HYDROXYCHLOROQUINE

Oztas M., Bektas M., Karacan I., Aliyeva N., Dag A., Aghamuradov S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1660-1661, 2022 (SCI-Expanded, Scopus)

35. A SYSTEMATIC REVIEW OF AA AMYLOIDOSIS AMONG PATIENTS WITH BEHCET'S SYNDROME

Karatemiz G., Esatoglu S. N., Gurcan M., Ozguler Y., Yurdakul S., Hamuryudan V., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1758-1759, 2022 (SCI-Expanded, Scopus)

36. DRUG SURVIVAL OF INFLIXIMAB IN BEHCET'S SYNDROME PATIENTS WITH DIFFERENT TYPES OF INVOLVEMENT

Esatoglu S. N., Tukek B., Taflan S. S., Ozyazgan Y., Ucar D., Hamuryudan V., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.697-698, 2022 (SCI-Expanded, Scopus)

37. SAFETY OF THE PFIZER/BIONTECH AND SINOVAC/CORONAVAC VACCINES AMONG PATIENTS WITH BEHCET'S SYNDROME AND FAMILIAL MEDITERRANEAN FEVER

Ozdede A., Guner S., Ozcifci G., Yurttas B., Dincer Z. T., Atli Z., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.962-963, 2022 (SCI-Expanded, Scopus)

38. Patients with rheumatic diseases are ready to use social media in clinical practice; what about rheumatologists? A cross-sectional survey

Erdogan M., Aydin O., SEYAHİ E.

RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.4, ss.717-723, 2022 (SCI-Expanded, Scopus)

39. Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center

Oztas M., Ozgul H., Seyahi E., Ugurlu S.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.4, ss.917-925, 2022 (SCI-Expanded, Scopus, TRDizin)

40. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behcet's syndrome

Ozcifci G., Aydin T., Atli Z., BALKAN İ. İ., TABAK Ö. F., ÖZTAŞ M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.1, ss.101-113, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly

SEYAHİ E., BAKHDIYARLI G., ÖZTAŞ M., KUŞKUCU M. A., TOK Y., SÜT N., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.41, sa.8, ss.1429-1440, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. EMERGENCE OF DE NOVO MANIFESTATIONS DURING INFLIXIMAB TREATMENT IN BEHCET SYNDROME

Tukek B., Esatoglu S. N., Hatemi G., Caliskan E. B., Ozyazgan Y., Ucar D., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.662-663, 2021 (SCI-Expanded, Scopus)

43. DRUG RETENTION RATE, REASONS FOR DISCONTINUATION AND OUTCOME OF INFLIXIMAB USE IN BEHCET SYNDROME

Esatoglu S. N., Tukek B., Taflan S. S., Ozyazgan Y., Ucar D., Hamuryudan V., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.660-661, 2021 (SCI-Expanded, Scopus)

44. CAUSES OF HOSPITALIZATION IN BEHCET SYNDROME

Ozguler Y., Hatemi G., Pala A. S., Esatoglu S. N., UĞURLU S., SEYAHİ E., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.958, 2021 (SCI-Expanded, Scopus)

45. WILLINGNESS TO GET THE COVID-19 VACCINE AMONG PATIENTS WITH RHEUMATIC DISEASES, HEALTH WORKERS AND GENERAL POPULATION

Yurttas B., Poyraz B. Ç., Sut N., Ozdede A., Oztas M., TABAK Ö. F., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.875, 2021 (SCI-Expanded, Scopus)

46. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey

YURTTAŞ B., POYRAZ B. Ç., SÜT N., Ozdede A., ÖZTAŞ M., UĞURLU S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.41, sa.6, ss.1105-1114, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. COVID-19 Among Patients With Inflammatory Rheumatic Diseases

Esatoglu S. N., Tascilar K., Babaoglu H., Bes C., YURTTAŞ B., AKAR S., et al.

FRONTIERS IN IMMUNOLOGY , cilt.12, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

Ortiz-Fernández L., Saruhan-Direskeneli G., Alibaz-Oner F., Kaymaz-Tahra S., Coit P., Kong X., et al.

American Journal of Human Genetics , cilt.108, sa.1, ss.84-99, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

49. One year in review 2021: Behçet's syndrome.

Hatemi G., SEYAHİ E., Fresko I., Talarico R., Ucar D., Hamuryudan V.

Clinical and experimental rheumatology , cilt.39, sa.5, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

50. Occipital neuralgia as a manifestation of neuro-Behcet's relapse: a case report

Gulec Z. E., SEYAHİ E., Uygunoglu U.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.5, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Characteristics and outcomes of Behcet's syndrome patients with Coronavirus Disease 2019: a case series of 10 patients

YURTTAŞ B., ÖZTAŞ M., TUNÇ A., BALKAN İ. İ., TABAK Ö. F., HAMURYUDAN V., et al.

INTERNAL AND EMERGENCY MEDICINE , cilt.15, sa.8, ss.1567-1571, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. One year in review 2020: Behçet's syndrome

Hatemi G., Seyahi E., Fresko İ., Talarico R., HAMURYUDAN V.

Clinical and experimental rheumatology , cilt.38, sa.5, ss.3-10, 2020 (SCI-Expanded, Scopus)

53. Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide.

Gurcan M., Esatoglu S. N., Hamuryudan V., Saygin D., Ugurlu S., Seyahi E., et al.

Rheumatology (Oxford, England) , cilt.59, sa.9, ss.2264-2271, 2020 (SCI-Expanded, Scopus)

54. Investigation of clinical profile of Behçet's syndrome-related versus idiopathic branch retinal vein occlusion.

Ucar D., Mergen B., Gonen B., Ozguler Y., Seyahi E., Hamuryudan V., et al.

Indian journal of ophthalmology , cilt.68, sa.9, ss.1876-1880, 2020 (SCI-Expanded, Scopus)

55. The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey

SEYAHİ E., POYRAZ B. Ç., SÜT N., AKDOĞAN S., HAMURYUDAN V.

RHEUMATOLOGY INTERNATIONAL , cilt.40, sa.8, ss.1229-1238, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. Comment on: Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome: Reply

Ozguler Y., Hatemi G., Cetinkaya F., Tascilar K., Hamuryudan V., Ugurlu S., et al.

Rheumatology (United Kingdom) , cilt.59, sa.4, ss.914-915, 2020 (SCI-Expanded, Scopus)

57. Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome

Ozguler Y., Hatemi G., Cetinkaya F., Tascilar K., Hamuryudan V., Ugurlu S., et al.

Rheumatology (United Kingdom) , cilt.59, sa.4, ss.799-806, 2020 (SCI-Expanded, Scopus)

58. Peripheral blood mononuclear cell proteome profile in Behçet’s syndrome

Aydin A. K., Ozguler Y., Ucar D., KASAP M., AKPINAR G., Seyahi E., et al.

Rheumatology International , cilt.40, sa.1, ss.65-74, 2020 (SCI-Expanded, Scopus)

59. Takayasu's arteritis: associated inflammatory diseases

Esatoglu S. N., Ok A. M., Ucar D., Celik A. F., Ugurlu S., Hamuryudan V., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.38, sa.2, 2020 (SCI-Expanded, Scopus)

60. Current surgical approaches in Takayasu's arteritis: a single-centre experience.

Arslan C., Tel Ç., Arapi B., Esatoglu S. N., Besirli K., Bozkurt A., et al.

Clinical and experimental rheumatology , cilt.38, sa.2, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Venous involvement in inflammatory disorders

Seyahi E.

CURRENT OPINION IN RHEUMATOLOGY , cilt.32, sa.1, ss.29-34, 2020 (SCI-Expanded, Scopus)

62. Outcome of invasive procedures for venous thrombosis in Behçet's syndrome: case series and systematic literature review.

Dincses E., Esatoglu S. N., Fresko İ., MELİKOĞLU M., Seyahi E.

Clinical and experimental rheumatology , sa.6, ss.125-131, 2019 (SCI-Expanded, Scopus)

63. Increased frequency of obstructive sleep apnea syndrome in Behçet's syndrome patients with superior vena cava syndrome.

Gokturk A., Esatoglu S. N., Atahan E., HAMURYUDAN V., Yazici H., Seyahi E.

Clinical and experimental rheumatology , sa.6, ss.132-136, 2019 (SCI-Expanded, Scopus)

64. One year in review 2019: Behçet's syndrome

Hatemi G., Seyahi E., Fresko İ., Talarico R., Hamuryudan V.

Clinical and experimental rheumatology , cilt.37, sa.6, ss.3-17, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

65. Familial Mediterranean fever: misdiagnosis and diagnostic delay in Turkey

Erdogan M., Ugurlu S., Ozdogan H., Seyahi E.

Clinical and experimental rheumatology , cilt.37, sa.6, ss.119-124, 2019 (SCI-Expanded, Scopus)

66. Is sirolimus a treatment option for patients with systemic lupus erythematosus?

Esatoglu S. N., SEYAHİ E.

Clinical and experimental rheumatology , sa.6, ss.13, 2019 (SCI-Expanded, Scopus)

67. Increased vein wall thickness in Behcet disease

Seyahi E., Gjoni M., Durmaz E. S., Akbas S., Süt N., Dikici A. S., et al.

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS , cilt.7, sa.5, ss.677-686, 2019 (SCI-Expanded, Scopus)

68. Assessment of deep venous thrombosis in the lower extremity in Behcet's syndrome: MR venography versus Doppler ultrasonography

Tutar B., Kantarci F., Cakmak O. S., Yazici H., Seyahi E.

INTERNAL AND EMERGENCY MEDICINE , cilt.14, sa.5, ss.705-711, 2019 (SCI-Expanded, Scopus)

69. Phenotypes in Behcet's syndrome

Seyahi E.

INTERNAL AND EMERGENCY MEDICINE , cilt.14, sa.5, ss.677-689, 2019 (SCI-Expanded, Scopus)

70. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study

Karacan İ., Balamir A., Ugurlu S., Aydin A. K., Everest E., Zor S., et al.

RHEUMATOLOGY INTERNATIONAL , sa.5, ss.911-919, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Secukinumab induced Behcet's syndrome: a report of two cases

DİNÇSES NAS E., YURTTAŞ B., ESATOĞLU S. N., MELİKOĞLU M., HAMURYUDAN V., SEYAHİ E.

OXFORD MEDICAL CASE REPORTS , sa.5, ss.239-241, 2019 (ESCI, Scopus)

72. Biosimilar infliximab for Behcet's syndrome: a case series

Dincses E., Esatoglu S. N., Ozguler Y., Uygunoglu U., Hamuryudan V., Seyahi E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.111-115, 2019 (SCI-Expanded, Scopus)

73. Surgical Treatment of Pulmonary Complications in Behçet's Syndrome

Tuzun H., Seyahi E., Guzelant G., Oz B., Batur Ş., Demirhan O., et al.

Seminars in Thoracic and Cardiovascular Surgery , cilt.30, sa.3, ss.369-378, 2018 (SCI-Expanded, Scopus)

74. Retrospective Analysis of Initial Presentation Findings of Behcet's Syndrome throughout 4 Decades

Dincses E., Ozguler Y., Ucar D., Ozyazgan Y., Ugurlu S., Hatemi G., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

75. Use of Social Media Among Patients with Rheumatic Diseases

Erdogan M., Aydin O., Seyahi E.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

76. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies

Ayan G., Esatoglu S. N., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.38, sa.4, ss.607-622, 2018 (SCI-Expanded, Scopus)

77. Behcet syndrome: a contemporary view

Yazici H., Seyahi E., Hatemi G., Yazici Y.

NATURE REVIEWS RHEUMATOLOGY , cilt.14, sa.2, ss.107-119, 2018 (SCI-Expanded, Scopus)

78. One year in review 2018: Behçet’s syndrome

Hatemi G., Seyahi E., Fresko İ., TALARICO R., Hamuryudan V.

Clinical and Experimental Rheumatology , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)

79. Exacerbation of Behçet's syndrome and familial Mediterranean fever with menstruation.

Guzelant G., Ozguler Y., Esatoglu S. N., Karatemiz G., Ozdogan H., Yurdakul S., et al.

Clinical and experimental rheumatology , sa.6, ss.95-99, 2017 (SCI-Expanded, Scopus)

80. Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Guzelant G., Ucar D., Esatoglu S. N., Hatemi G., Ozyazgan Y., Yurdakul S., et al.

Clinical and experimental rheumatology , sa.6, ss.86-89, 2017 (SCI-Expanded, Scopus)

81. Surgical Therapies in the Treatment of Pulmonary Artery Involvement in Behcet's Syndrome

Tuzun H., Guzelant G., Demirhan O., Oz B., Fresko I., Hamuryudan V., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

82. Cardiovascular Risk Factors and Comorbid Diseases in Takayasu's Arteritis

Masyan H., Esatoglu S. N., Celik A. M., Hamuryudan V., Yazici H., Seyahi E.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

83. Myelopathy in Behçet's disease: The Bagel Sign

Uygunoglu U., Zeydan B., Ozguler Y., Ugurlu S., Seyahi E., Kocer N., et al.

Annals of Neurology , cilt.82, sa.2, ss.288-298, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

84. About the AIRTRIP randomised clinical trial: comments on the article by Brucato et al.

Dincses E., Seyahi E.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.35, sa.2, 2017 (SCI-Expanded, Scopus)

85. Missing Information About Disease Controls: Comment on the Article by Mangnus et al

Esatoglu S. N., Seyahi E., Yazici H.

ARTHRITIS & RHEUMATOLOGY , cilt.69, sa.3, ss.678, 2017 (SCI-Expanded, Scopus)

86. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility

TAKEUCHI M., MIZUKI N., MEGURO A., OMBRELLO M. J., KIRINO Y., SATORIUS C., et al.

NATURE GENETICS , cilt.49, sa.3, ss.438-443, 2017 (SCI-Expanded, Scopus)

87. One year in review 2017: Behçet's syndrome

Hatemi G., Seyahi E., Fresko İ., Talarico R., Hamuryudan V.

Clinical and Experimental Rheumatology , cilt.35, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

88. Takayasu arteritis: an update

Seyahi E.

CURRENT OPINION IN RHEUMATOLOGY , cilt.29, sa.1, ss.51-56, 2017 (SCI-Expanded, Scopus)

89. Inadequate reporting of enrolled patient and study site characteristics, and inter-study site differences in randomized controlled trials: A systematic review in six leading medicine journals

Yurdakul S., Ayan G., Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., et al.

European Journal of Internal Medicine , cilt.37, 2017 (SCI-Expanded, Scopus)

90. Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci Ş., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.36, sa.12, ss.1719-1725, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

91. A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behcet's disease in HLA-B(star)51 carriers

TAKEUCHI M., OMBRELLO M. J., KIRINO Y., Erer B., Tugal-Tutkun I., Seyahi E., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.75, sa.12, ss.2208-2211, 2016 (SCI-Expanded, Scopus)

92. Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behcet's disease

ERER B., TAKEUCHI M., Ustek D., Tugal-Tutkun I., Seyahi E., Ozyazgan Y., et al.

GENES AND IMMUNITY , cilt.17, sa.7, ss.396-399, 2016 (SCI-Expanded, Scopus)

93. RELATIONSHIP BETWEEN MENSTRUATION AND SYMPTOMS OF BEHCET'S SYNDROME

Guzelant G., Ozguler Y., Esatoglu N. S., Karatemiz G., Ozdogan H., Yurdakul S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

94. EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME

Guzelant G., Ucar D., Hatemi G., Ozyazgan Y., Esatoglu N. S., Yurdakul S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

95. One year in review 2016: Belicet's syndrome

Hatemi G., Seyahi E., Fresko İ., TALARICO R., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

96. Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behcet's syndrome patients with pulmonary artery involvement during follow-up

Esatoglu S. N., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

97. Effect of colchicine on serum lipid levels

Ugurlu S., Seyahi E., Hanci I., PEHLEVAN S., Ozdogan H., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

98. BEHCET'S SYNDROME ASSOCIATED WITH TAKAYASU'S ARTERITIS: A CASE SERIES OF 10 PATIENTS

Esatoglu S. N., Seyahi E., Ugurlu S., Hatemi G., Melikoglu M., Hamuryudan V., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

99. Infliximab is a plausible alternative for neurologic complications of Behcet disease

Zeydan B., Uygunoglu U., Saip S., Demirci O. N., Seyahi E., Ugurlu S., et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , cilt.3, sa.5, 2016 (SCI-Expanded, Scopus)

100. Novel Susceptible Genes for Behcet's Disease Identified By Dense Genotyping of Immune-Related Loci Implicate Host Responses to Microbial Exposure

Takeuchi M., Mizuki N., Meguro A., Ombrello M. J., Kirino Y., Satorius C., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

101. Behcet's disease: How to diagnose and treat vascular involvement

Seyahi E.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY , cilt.30, sa.2, ss.279-295, 2016 (SCI-Expanded, Scopus)

102. Behcet syndrome: the vascular cluster

Yazici H., Seyahi E.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.46, sa.5, ss.1277-1280, 2016 (SCI-Expanded, Scopus, TRDizin)

103. To anticoagulate or not vascular thrombosis in Behcet's syndrome: an enduring question

Seyahi E., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.1, 2016 (SCI-Expanded, Scopus)

104. Pulmonary artery involvement in Behçet's syndrome: Effects of anti-Tnf treatment

Hamuryudan V., Seyahi E., Ugurlu S., Melikoglu M., Hatemi G., Ozguler Y., et al.

Seminars in Arthritis and Rheumatism , cilt.45, sa.3, ss.369-373, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

105. Behcet's syndrome: a critical digest of the 2014-2015 literature

Hatemi G., Seyahi E., Fresko İ., Talarico R., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

106. Clinical and Ultrasonographic Evaluation of Lower-extremity Vein Thrombosis in Behcet Syndrome

Seyahi E., Cakmak O. S., Tutar B., Arslan C., Dikici A. S., Sut N., et al.

Medicine (United States) , cilt.94, sa.44, 2015 (SCI-Expanded, Scopus)

107. Can We Differentiate Takayasu's Arteritis from Atherosclerosis Using Carotid Artery Doppler Usg?

UĞURLU S., KESKİN F. E., CETINKAYA F., MELİKOĞLU M., HAMURYUDAN V., FRESKO İ., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

108. Takayasu's Arteritis Associated with Behcet's Syndrome: A Case Series of 8 Patients

Esatoglu S. N., Seyahi E., Ugurlu S., Hatemi G., Melikoglu M., Hamuryudan V., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

109. Bronchial Artery Enlargement May Cause Recurring Hemoptysis in Behcet's Syndrome Patients with Pulmonary Artery Involvement Despite Response to Treatment

Hamuryudan V., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

110. Methylation Analysis of HLA-B Locus in Familial Behcet Syndrome

Turanli E. T., Koprulu P., Ugurlu S., Yazici H., Seyahi E.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

111. Identification of ERAP1 protein allotypes in the Turkish population and evaluation of their contributions to Behçet's disease risk

Remmers E., Takeuchi M., Ombrello M., Kirino Y., Erer B., Tugal-Tutkun I., et al.

Pediatric Rheumatology , cilt.13, sa.1, 2015 (SCI-Expanded, Scopus)

112. Restarting biologic agents in rheumatology patients who developed tuberculosis under TNF alpha-inhibitor treatment

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci S., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.46, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

113. Venous claudication in Behçet's disease

Ugurlu S., Seyahi E., Oktay V., Kantarci F., Tuzun H., Yigit Z., et al.

Journal of Vascular Surgery , cilt.62, sa.3, ss.698, 2015 (SCI-Expanded, Scopus)

114. An outcome survey of 43 patients with Budd-Chiari syndrome due to Behcet's syndrome followed up at a single, dedicated center

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.44, sa.5, ss.602-609, 2015 (SCI-Expanded, Scopus)

115. Response to the letter by Andrea Mancuso

Yazici H., SEYAHİ E.

Seminars in Arthritis and Rheumatism , cilt.45, sa.1, 2015 (SCI-Expanded, Scopus)

116. Behcet's syndrome: pulmonary vascular disease

Seyahi E., Yazici H.

CURRENT OPINION IN RHEUMATOLOGY , cilt.27, sa.1, ss.18-23, 2015 (SCI-Expanded, Scopus)

117. Identification of susceptibility loci in IL6, RPS9/LILRB3, and an intergenic locus on chromosome 21q22 in takayasu arteritis in a genome-wide association study

RENAUER P. A., Saruhan-Direskeneli G., COIT P., ADLER A., AKSU K., KESER G., et al.

Arthritis and Rheumatology , cilt.67, sa.5, ss.1361-1368, 2015 (SCI-Expanded, Scopus)

118. 18F-FDG PET/CT in Vascular Disease Due to Behcet's Syndrome.

Seyahi E., Hallac M., Vatankulu B., Ugurlu S., Melikoglu M., Yurdakul S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

119. Interferon Alfa-Associated Depression in Patients with Behcet's Syndrome.

Keskin Y., Seyahi E., Poyraz C., Ugurlu S., Ozyazgan Y., Yazici H.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

120. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome.

Melikoglu M., Ozguler Y., Ugurlu S., Cetinkaya F., Tascilar K., Seyahi E., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

121. Evaluation of KIR3DL1/KIR3DS1 Association with Behcet's Disease in Turkish Individuals.

Erer B., Remmers E. F., Takeuchi M., Satorius C., Ustek D., Tugal-tutkun I., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

122. Anti-TNF Treatment for Refractory Vascular Involvement of Behcet's Syndrome.

Hamuryudan V., Seyahi E., Melikoglu M., Ugurlu S., Hatemi G., Yurdakul S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

123. Budd-Chiari Syndrome Due to Behcet's Syndrome: Some Patients Present without Liver Related Symptoms and Have a Better Outcome.

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

124. Right ventricular thrombus and tricuspid valve dysfunction in a patient with Behcet's syndrome

ARSLAN C., Arapi B., SEYAHI E., TEL Ç., TÜZÜN K. H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)

125. Behcet's syndrome: a critical digest of the 2013-2014 literature

Hatemi G., Seyahi E., Fresko İ., Talarico R., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

126. Inadequate Description and Discussion of Enrolled Patient Characteristics and Potential Inter-Study Site Differences in Reports of Randomized Controlled Trials: A Systematic Survey in Six Rheumatology Journals

Yurdakul S., Mustafa B. N., Fresko I., Seyahi E., Yazici H.

ARTHRITIS & RHEUMATOLOGY , cilt.66, sa.5, ss.1395-1399, 2014 (SCI-Expanded, Scopus)

127. Interferon alpha-associated depression in patients with Behçet's syndrome: A prospective controlled study

Keskin Y., Seyahi E., Poyraz C., Ugurlu S., Ozyazgan Y., Yazici H.

Clinical and Experimental Rheumatology , cilt.32, 2014 (SCI-Expanded, Scopus)

128. Vein wall imaging in Behçet's syndrome

Kantarci F., Seyahi E.

Clinical and Experimental Rheumatology , cilt.32, 2014 (SCI-Expanded, Scopus)

129. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome

Ozguler Y., Melikoglu M., Ugurlu S., Cetinkaya F., Tascilar E. K., Seyahi E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)

130. Colchicine in behçet syndrome: A longterm survey of patients in a controlled trial

Hamuryudan V., Hatemi G., Tascilar K., Yurdakul S., Mat C., Ozyazgan Y., et al.

Journal of Rheumatology , cilt.41, sa.4, ss.735-738, 2014 (SCI-Expanded, Scopus)

131. Pregnancy and Behcet's disease: comment on the article by Noel et al

Seyahi E., Yazici H.

ARTHRITIS AND RHEUMATISM , cilt.65, sa.11, ss.3007, 2013 (SCI-Expanded, Scopus)

132. Fever in Behçet's syndrome

Seyahi E., Karaaslan H., Ugurlu S., Yazici H.

Clinical and Experimental Rheumatology , cilt.31, 2013 (SCI-Expanded, Scopus)

133. Identification of multiple genetic susceptibility loci in Takayasu arteritis

Saruhan-Direskeneli G., HUGHES T., AKSU K., KESER G., COIT P., AYDIN S., et al.

American Journal of Human Genetics , cilt.93, sa.2, ss.298-305, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

134. Aortic and coronary calcifications in Takayasu arteritis

Seyahi E., Ucgul A., Olgun D. C., Ugurlu S., Akman C., Tutar O., et al.

Seminars in Arthritis and Rheumatism , cilt.43, sa.1, ss.96-104, 2013 (SCI-Expanded, Scopus)

135. Behcet's syndrome: a critical digest of the 2012-1213 literature

Hatemi G., Seyahi E., Fresko I., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.31, sa.3, 2013 (SCI-Expanded, Scopus)

136. **Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1**

Kirino Y., Bertsias G., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.

NATURE GENETICS , cilt.45, sa.2, ss.202-207, 2013 (SCI-Expanded, Scopus)

137. Major vessel thrombosis in Behçet's disease: The dilemma of anticoagulant therapy - The approach of rheumatologists from different countries

Tayer-Shifman O. E., Seyahi E., Nowatzky J., Ben-Chetrit E.

Clinical and Experimental Rheumatology , cilt.30, sa.5, ss.735-740, 2012 (SCI-Expanded, Scopus)

138. Behçet syndrome: Is it one condition?

Yazici H., Ugurlu S., Seyahi E.

Clinical Reviews in Allergy and Immunology , cilt.43, sa.3, ss.275-280, 2012 (SCI-Expanded, Scopus)

139. PDCD1 polymorphisms are not associated with Takayasu's arteritis in Turkey

Direskeneli H., Tuna-Erdoǧan E., Gündüz F., Bandurska-Luque A., Alparslan B., Kebe M., et al.

Clinical and Experimental Rheumatology , cilt.30, 2012 (SCI-Expanded, Scopus)

140. Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever

Yucel I. K., Seyahi E., Kasapcopur O., Arisoy N.

RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.7, ss.1955-1962, 2012 (SCI-Expanded, Scopus)

141. Behcet's syndrome: a critical digest of the recent literature

Hatemi G., Seyahi E., Fresko İ., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.30, sa.3, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

142. **Takayasu's arteritis is associated with HLA-B52, but not with HLA-B51, in Turkey**

Sahin Z., Bicakcigil M., AKSU K., Kamali S., Akar S., ÖNEN F., et al.

ARTHRITIS RESEARCH & THERAPY , cilt.14, sa.1, 2012 (SCI-Expanded, Scopus)

143. Pulmonary Artery Involvement and Associated Lung Disease in Behcet Disease A Series of 47 Patients

Seyahi E., Melikoglu M., Akman C., Hamuryudan V., Ozer H., Hatemi G., et al.

MEDICINE , cilt.91, sa.1, ss.35-48, 2012 (SCI-Expanded, Scopus)

144. Canakinumab in a patient with juvenile Behçet's syndrome with refractory eye disease

Ugurlu S., Ucar D., Seyahi E., Hatemi G., Yurdakul S.

Annals of the Rheumatic Diseases , cilt.71, sa.9, ss.1591-1592, 2012 (SCI-Expanded, Scopus)

145. Management and prognosis of nonpulmonary large arterial disease in patients with Behcet disease

Tuzun H., Seyahi E., Arslan C., Hamuryudan V., Besirli K., Yazici H.

JOURNAL OF VASCULAR SURGERY , cilt.55, sa.1, ss.157-163, 2012 (SCI-Expanded, Scopus)

146. Clinical characteristics of pediatric-onset neuro-Behçet disease

Uluduz D., Kurtuncu M., Yapici Z., Seyahi E., Kasapcopur O., Ozdogan H., et al.

Neurology , cilt.77, sa.21, ss.1900-1905, 2011 (SCI-Expanded, Scopus)

147. Anti - saccharomyces cerevisiae (asca) and anti - neu trophil cytoplasmic (anca) antibodies are not increas ed in takayasu arteritis

Ozbakir F., UĞURLU S., ÇELİK A. F., SEYAHİ E.

Acta Reumatologica Portuguesa , cilt.36, sa.1, ss.20-23, 2011 (SCI-Expanded, Scopus)

148. Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever in Turkey

Kasapcopur O., Yucel İ. K., Seyahi E., Arisoy N.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.29, sa.2, ss.393, 2011 (SCI-Expanded, Scopus)

149. ANTI-SACCHAROMYCES CEREVISIAE [ASCA] AND ANTI-NEUTROPHIL CYTOPLASMIC [ANCA] ANTIBODIES ARE NOT INCREASED IN TAKAYASU ARTERITIS

Ozbakir F., Ugurlu S., Çelik A. B., Seyahi E.

ACTA REUMATOLOGICA PORTUGUESA , cilt.36, sa.1, ss.20-23, 2011 (SCI-Expanded, Scopus)

150. Behcet's Syndrome: Clinical Presentations Affecting Prognosis and Survival

Seyahi E., Tascilar K., Yazici H.

AUTOIMMUNE DISEASES: ACUTE AND COMPLEX SITUATIONS , ss.163-184, 2011 (SCI-Expanded)

151. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME (BS)

Hamuryudan V., Hatemi G., Yurdakul S., Tascilar K., Mat C., Ozyazgan Y., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

152. CURRENT TRENDS IN THE MANAGEMENT OF BEHCET'S SYNDROME

Hatemi G., Hamuryudan V., Tascilar K., Yurdakul S., Fresko I., Melikoglu M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

153. VENOUS SEVERITY ASSESSMENT IN BEHCET'S SYNDROME

Cakmak O. S., Seyahi E., Kantarci F., Yesilova A., Ergin A. S., Dikici A. S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

154. SOME MANIFESTATIONS DISAPPEAR EARLIER THAN OTHERS IN BEHCET'S SYNDROME

Sacli S., Seyahi E., Yilmaz O., Mat C., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

155. EYE DISEASE IN JUVENILE PATIENTS WITH BEHCET'S SYNDROME

Ozyazgan Y., Seyahi E., Sarica A., Ugurlu S., Hatemi G., Yurdakul S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

156. A twin study in Behçet's syndrome

Masatlioglu S., SEYAHİ E., Tahir Turanlı E., FRESKO İ., Gogus F., Senates E., et al.

Clinical and Experimental Rheumatology , cilt.28, 2010 (SCI-Expanded, Scopus)

157. The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey

SEYAHİ E., Tahir Turanlı E., Mangan M. S., Çelikyapi G., OKTAY V., Çevirgen D., et al.

Clinical and Experimental Rheumatology , cilt.28, 2010 (SCI-Expanded, Scopus)

158. ANTI-TNF THERAPY IN SEVERE UVEITIS OF BEHCET'S SYNDROME: REPORT OF 27 PATIENTS

Ugurlu S., Hamuryudan V., Ozyazgan Y., Seyahi E., Hatemi G., Yurdakul S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

159. Endothelial Dysfunction and Atherosclerosis in Behcet's Syndrome

Seyahi E., Fresko I., Yazici H.

BEHCET'S SYNDROME , ss.135-148, 2010 (SCI-Expanded)

160. Juvenile Behcet's Syndrome

Seyahi E., Oezdogan H.

BEHCET'S SYNDROME , ss.205-214, 2010 (SCI-Expanded)

161. Prognosis in Behcet's Syndrome

Seyahi E., Yazici H.

BEHCET'S SYNDROME , ss.285-298, 2010 (SCI-Expanded)

162. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial

Hamuryudan V., Hatemi G., Tascilar K., Sut N., Ozyazgan Y., Seyahi E., et al.

RHEUMATOLOGY , cilt.49, sa.1, ss.173-177, 2010 (SCI-Expanded, Scopus)

163. Comment on "Cardiac Behcet Disease Presenting as Aortic Valvulitis/Aortitis or Right Heart Inflammatory Mass: A Clinicopathologic Study of 12 Cases"

Hamuryudan V., Seyahi E., Yazici H.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY , cilt.32, sa.12, ss.1914-1915, 2008 (SCI-Expanded, Scopus)

164. Behcet's Syndrome Is Not So Rare: Why Do We Need to Know?

Yazici H., Seyahi E., Yurdakul S.

ARTHRITIS AND RHEUMATISM , cilt.58, sa.12, ss.3640-3643, 2008 (SCI-Expanded, Scopus)

165. The unique features of vasculitis in Behcet's syndrome

Melikoglu M., Kural-Seyahi E., Tascilar K., Yazici H.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY , cilt.35, ss.40-46, 2008 (SCI-Expanded, Scopus)

166. Atherosclerosis in Behcet's syndrome

Seyahi E., Ugurlu S., Cumali R., Balci H., Ozdemir O., Melikoglu M., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.38, sa.1, ss.1-12, 2008 (SCI-Expanded, Scopus)

167. INFLIXIMAB IN 10 PATIENTS WITH BEHCET'S OCULAR INVOLVEMENT

Ozyazgan Y., Sarica A., Seyahi E., Hatemi G., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

168. THE LONG TERM PROGNOSIS OF BEHCET'S SYNDROME AMONG MEN WITH SKIN-MUCOSA INVOLVEMENT AT ONSET: RE-EVALUATION OF A COHORT OF PATIENTS ENROLLED IN A CONTROLLED TRIAL

Hamuryudan V., Hatemi G., Tascilar K., Ozyazgan Y., Seyahi E., Mat C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

169. Relapsing polychondritis in a patient with familial Mediterranean fever and amyloidosis

Salihoglu A., Seyahi E., Celik S., Yurdakul S.

Clinical and Experimental Rheumatology , cilt.26, 2008 (SCI-Expanded, Scopus)

170. Atherosclerosis in Behçet's syndrome

SEYAHİ E., Yazici H.

Clinical and Experimental Rheumatology , cilt.25, 2007 (SCI-Expanded, Scopus)

171. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome

Seyahi E., Hamuryudan V., Hatemi G., Melikoglu M.

RHEUMATOLOGY , cilt.46, sa.7, ss.1213-1214, 2007 (SCI-Expanded, Scopus)

172. A cost analysis of Behçet's syndrome in Turkey

Sut N., Seyahi E., Yurdakul S., Senocak M., Yazici H.

Rheumatology , cilt.46, sa.4, ss.678-682, 2007 (SCI-Expanded, Scopus)

173. Homozygous factor V Leiden mutation and disseminated thrombosis in a patient with nephrotic syndrome.

Kahveci A., Seyahi N., Seyahi E., Altiparmak M. R., Ataman R., Serdengecti K.

Journal of nephrology , cilt.20, sa.1, ss.103-6, 2007 (SCI-Expanded, Scopus)

174. Treatment options in colchicine resistant familial Mediterranean fever patients: Thalidomide and etanercept as adjunctive agents

Seyahi E., Ozdogan H., Celik S., Ugurlu S., Yazici H.

Clinical and Experimental Rheumatology , cilt.24, 2006 (SCI-Expanded, Scopus)

175. Atherosclerosis in Takayasu arteritis

Seyahi E., Ugurlu S., Cumali R., Balci H., Seyahi N., Yurdakul S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.65, sa.9, ss.1202-1207, 2006 (SCI-Expanded, Scopus)

176. Hair diameter in systemic lupus erythematosus

Seyahi E., Seyahi N., Fresko İ., Kuyumcu M., Yazici H.

Lupus , cilt.15, sa.5, ss.282-284, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

177. The management of Behçet's syndrome.

SEYAHİ E., FRESKO İ., MELİKOĞLU M., Yazici H.

Acta reumatológica portuguesa , cilt.31, sa.2, ss.125-131, 2006 (SCI-Expanded, Scopus)

178. Headache in Behcet's syndrome

Saip S., Siva A., Altintas A., Kiyat A., Seyahi E., Hamuryudan V., et al.

HEADACHE , cilt.45, sa.7, ss.911-919, 2005 (SCI-Expanded, Scopus)

179. Pulmonary artery aneurysms in Behcet syndrome

Hamuryudan V., Er T., Seyahi E., Akman C., Tuzun H., Fresko İ., et al.

AMERICAN JOURNAL OF MEDICINE , cilt.117, sa.11, ss.867-870, 2004 (SCI-Expanded, Scopus)

180. Coronary atherosclerosis in Behcet's syndrome: a pilot study using electron-beam computed tomography

Seyahi E., Memisoglu E., Hamuryudan V., Tepe S., Aker U., Balci H., et al.

RHEUMATOLOGY , cilt.43, sa.11, ss.1448-1450, 2004 (SCI-Expanded, Scopus)

181. Infliximab and primary Sjögren's syndrome: Comment on the article by Mariette et al [3] (multiple letters)

Fresko İ., Seyahi E., Yurdakul S.

Arthritis and Rheumatism , cilt.50, sa.12, ss.4077, 2004 (SCI-Expanded, Scopus)

182. The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center

Kural-Seyahi E., Fresko I., Seyahi N., Ozyazgan Y., Mat C., Hamuryudan V., et al.

MEDICINE , cilt.82, sa.1, ss.60-76, 2003 (SCI-Expanded, Scopus)

183. Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient

Seyahi E., Ozdogan H., Masatlioglu S., Yazici H.

Clinical and Experimental Rheumatology , cilt.20, 2002 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 48

1. Mepolizumab in rare eosinophilic disorders: A real-life study

Demir S., Korkmaz P., Karabacak D. E., Unal D., Ince B., Erdem S., et al.

Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Hamburg, Almanya, 9 - 11 Haziran 2023, (Özet Bildiri)

2. ETIOLOGICAL EVALUATION AND MORTALITY OF PATIENTS WITH RENAL ARTERY STENOSIS

SERİN İ., TRABULUS S., SEYAHİ N., SEYAHİ E.

56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest, Macaristan, 13 - 16 Haziran 2019, cilt.34, (Özet Bildiri)

3. CLINICAL CHARACTERISTICS OF OLDER AGE- ONSET BEHCET SYNDROME PATIENTS

GÜZELANT ÖZKÖSE G., ÖZYAZGAN Y., Mat C., HAMURYUDAN V., YAZICI H., SEYAHİ E.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.991-992, (Özet Bildiri)

4. DISEASE CHARACTERISTICS AND OUTCOME OF PATIENTS WITH RENAL ARTERY STENOSIS FOLLOWED BY A SINGLE NEPHROLOGY CENTER

SERİN İ., TRABULUS S., SEYAHİ N., SEYAHİ E.

5. SOCIAL MEDIA USE IN RHEUMATOLOGY PATIENTS

Erdogan M., Aydin O., Seyahi E.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.2067, (Özet Bildiri)

6. MYCOPHENOLATE MOFETIL IN THE TREATMENT OF MAJOR ORGAN INVOLVEMENT OF PATIENTS WITH BEHCET'S SYNDROME

ESATOĞLU S. N., Cemre E., HAMURYUDAN V., ÖZYAZGAN Y., UÇAR D., KUTLUBAY Z., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.820, (Özet Bildiri)

7. INITIAL MANIFESTATIONS AND OUTCOME OF PATIENTS WITH INCOMPLETE BEHCET'S SYNDROME

ESATOĞLU S. N., BİLGİN S., SULU C., HAMURYUDAN V., KUTLUBAY Z., UĞURLU S., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.428, (Özet Bildiri)

8. A DECLINING TREND IN FREQUENCY OF SECONDARY AMYLOIDOSIS IN BEHCET'S SYNDROME

Esatoglu S. N., Hatemi G., Karatemiz G., Ozguler Y., Yurdakul S., Hamuryudan V., et al.

19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)

9. INTERFERON-ALPHA FOR THE MANAGEMENT OF LOWER EXTREMITY DEEP VEIN THROMBOSIS IN BEHCET'S SYNDROME: A CASE SERIES

Ozguler Y., Hatemi G., Cetinkaya F., Tascilar K., Ugurlu S., Seyahi E., et al.

19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)

10. LONG TERM FOLLOW-UP OF BEHCET'S SYNDROME PATIENTS TREATED WITH CYCLOPHOSPHAMIDE

Gurcan M., Esatoglu S. N., Hamuryudan V., SAYGIN C., SAYGIN D., Ugurlu S., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1492-1493, (Özet Bildiri)

11. Could neurological involvement in Behcet's Disease occur atypically?

Siva A., Esatoglu S. N., Uygunoglu U., Ozguler Y., Hatemi G., Tutuncu M., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)

12. Does Co-morbidity with Familial Mediterranean Fever change the course of Multiple Sclerosis?

Siva A., Tutuncu M., Uygunoglu U., Erdogan M., Ugurlu S., Ozcan B., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)

13. Bagel Sign in neuro-Behcet's Syndrome

Uygunoglu U., Zeydan B., Ozguler Y., Ugurlu S., Seyahi E., Kocer N., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)

14. ASSOCIATED INFLAMMATORY DISEASES IN TAKAYASU'S ARTERITIS: THE MANY FACES OF A DISEASE

Esatoglu S. N., Celik A. M., Ucar D., Ugurlu S., Hatemi G., Hamuryudan V., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.47, (Özet Bildiri)

15. AN OUTCOME SURVEY OF 100 PATIENTS WITH CEREBRAL VENOUS SINUS THROMBOSIS DUE TO BEHCET'S SYNDROME FOLLOWED UP AT A SINGLE, DEDICATED CENTER

Kurt E. A., Ozguler Y., Kocer N., Ucar D., Uygunoglu U., Saip S., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.89-90, (Özet Bildiri)

16. COMORBID DISEASES AND CARDIOVASCULAR RISK FACTORS IN TAKAYASU'S ARTERITIS PATIENTS

Masyan H., Masyan H., Esatoglu S. N., Celik A. M., Hamuryudan V., Yazici H., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.47-48, (Özet Bildiri)

17. EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME

Guzelant G., Guzelant G., Ucar D., Hatemi G., Ozyazgan Y., Esatoglu S. N., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri)

18. RITUXIMAB FOR ANCA ASSOCIATED VASCULITIS REFRACTORY TO CONVENTIONAL TREATMENT: A RETROSPECTIVE STUDY ON 25 PATIENTS

Ayan G., Ugurlu S., Hatemi G., Seyahi E., Melikoglu M., Fresko I., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.153-154, (Özet Bildiri)

19. CAN WE DIFFERENTIATE TAKAYASU'S ARTERITIS FROM ATHEROSCLEROSIS USING CAROTID ARTERY DOPPLER USG?

Seyahi E., Esatoglu S. N., Ugurlu S., Keskin F. E., CETINKAYA F., Melikoglu M., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.46-47, (Özet Bildiri)

20. How to Differentiate Longitudinally Extensive Transverse Myelitis of Neuro-Behcet Syndrome from Neuromyelitis Optica Spectrum Disorders?

Siva A., Uygunoglu U., Zeydan B., Tutuncu M., Ozguler Y., Seyahi E., et al.

9th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Bangkok, Tayland, 27 - 29 Ekim 2016, cilt.23, ss.342, (Özet Bildiri)

21. Infliximab for Treatment Refractory Neuro-Behcet Syndrome

Zeydan B., Uygunoglu U., Saip S., Demirci O., Seyahi E., Uguriu S., et al.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri)

22. Spinal Cord Involvement in Neuro-Behcet Syndrome

Zeydan B., Uygunoglu U., Seyahi E., Ugurlu S., Saip S., Kantarci O., et al.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri)

23. Venous Claudication Is A Severe and Frequent Symptom In BEHCET'S Syndrome

Ugurlu S., Seyahi E., Oktay V., Yigit Z., Kucukoglu S., Yazici H.

77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

24. High Density Genotyping Of Immune-Related Disease Genes Identifies 7 New Susceptibility Loci For Behcets Disease

Takeuchi M., Mizuki N., Meguro A., Ombrello M. J., Satorius C., Kirino Y., et al.

25. Infliximab For Sight-Threatening and Refractory Uveitis Of Behcet's Syndrome

Hamuryudan V., Hatemi G., Ozyazgan Y., Ucar D., Yurdakul S., Seyahi E., et al.

26. An Outcome Survey Of 40 Patients With Budd-Chiari Syndrome Due To BEHCET'S Syndrome Followed By A Single Center

Seyahi E., Ugurlu S., Caglar E., Kantarci F., Sonsuz A., Yurdakul S., et al.

27. Canakinumab In Patients With FMF

Ugurlu S., Seyahi E., Hatemi G., Hacioglu A., Ozdogan H.

77th Annual Meeting of the American-College-of-Rheumatology (ACR) / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

28. A CT Evaluation Of Pulmonary and Cardiac Lesions In BEHCET'S Syndrome Patients Without Pulmonary Symptoms

Seyahi E., Olgun D. C., Ugurlu S., Hanci I., Takahashi R., Yazici H.

29. Infliximab Treatment in Neuro-Behcet Disease Unresponsive to Immunosuppressive Treatments: Clinical Assessment of Eleven Patients

Zeydan B., Uygunoglu U., Seyahi E., Ugurlu S., Saipoglu S., Siva A.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 16 - 23 Mart 2013, cilt.80, (Özet Bildiri)

30. Aortic and Coronary Calcifications in Takayasu Arteritis

Seyahi E., Ucgul A., Ugurlu S., Akman C., Olgun D. C., Yurdakul S., et al.

Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

31. The Clinical Course of the Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome.

Ozguler Y., Melikoglu M., Cetinkaya F., Ugurlu S., Seyahi E., Tascilar K., et al.

Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

32. Targeted Deep Re-Sequencing Implicates Rare and Low Frequency Coding Variants in IL23R, MEFV, TLR4, and NOD2 in Behcet's Disease

Kirino Y., Zhou Q., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.

Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

33. **Genome-Wide Analysis Reveals a Recessive Association of ERAP1 Variants with Behcet's Disease and Epistasis Between ERAP1 and HLA-B*51.**

Remmers E. F., Kirino Y., Bertsias G., Ishigatsubo Y., Kim Y., Ombrello M. J., et al.

Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

34. Effect of Colchicine On Cholesterol Levels in Patients with Familial Mediterranean Fever and Behcet's Syndrome

Ugurlu S. L., Seyahi E., Hanci I., Ozdogan H., Masatlioglu-Pehlivan S., Yazici H.

Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

35. Genome-Wide Analysis of Imputed Genotypes Identifies Chemokine Receptor-1 CCR1) As a Novel Candidate Risk Locus in Behcet's Disease.

Kirino Y., Bertsias G., Ombrello M. J., Ustek D., Satorius C., Le J., et al.

75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)

36. Some Manifestations Disappear Earlier Than Others in Behcet's Syndrome

Sacli F. S., Seyahi E., Ugurlu S., Ozyazgan Y., Mat C., Yazici H.

37. Management and Prognosis of Non-Pulmonary Large Arterial Disease in Behcet's Syndrome: A Reappraisal of 25 Patients From a Single Center

Tuzun H., Seyahi E., Arslan C., Hamuryudan V., Besirli K., Yazici H.

38. ANTI-TNF THERAPY IN SEVERE UVEITIS OF BEHCET'S SYNDROME: REPORT OF 27 PATIENTS

Ugurlu S., Hamuryudan V., Ozyazgan Y., Seyahi E., Hatemi G., Yurdakul S., et al.

Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

39. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME

Hamuryudan V., Hatemi G., Yurdakul S., Mat C., Tascilar K., Ozyazgan Y., et al.

Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

40. Ailevi Akdeniz Ateşinde(AAA) Anti-Saccharomyces cerevisiae(ASCA) antikorları

ÖZBAKIR F., UĞURLU S., SEYAHİ E., ÇELİK A. F., ÖZDOĞAN A. H.

XI. Romatoloji Kongresi, Antalya, Türkiye, 13 - 17 Ekim 2010, cilt.2, sa.2, ss.134, (Tam Metin Bildiri)

41. Anti-Saccharomyces Cerevisiae(ASCA)Antibodies In Familial Mediterranean Fever(FMF)

ÖZBAKIR F., Uğurlu S., SEYAHİ E., ÇELİK A. F., ÖZDOĞAN A. H.

International Microscopy Congress(IMC17), Rio De Janeiro, Brezilya, 30 - 24 Eylül 2010, cilt.1, ss.17556, (Tam Metin Bildiri)

42. Kronik Hastalığı Olmayan Yaşlı Topluluğunda İmmün Gen Belirteçlerinin Analizleri: IL-6, IL-10 ve TNF-A Sonuçları

TAHİR TURANLI E., ERDİNÇLER Ü. D., ÇURGUNLU A., BOLAYIRLI İ. M., SEYAHİ E., BEĞER T., et al.

Akademik Geriatri Kongresi,, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.158-159, (Tam Metin Bildiri)

43. Kronik Hastalığı Olmayan Yaşlı Popülasyonunda Kalp-Damar Genetik Belirteçlerinin Analizleri

Tahir Turanlı E., Daşdemir S., Erdinçler Ü. D., Çurgunlu A., Bolayırlı İ. M., Seyahi E., et al.

Akademik Geriatri Kongresi,, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.160, (Tam Metin Bildiri)

44. Subclinical atherosclerosis in familial Mediterranean fever

Ugurlu S., Seyahi E., Cetinkaya F., Ozbakir F., Balci H., Ozdogan H.

72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Kostarika, 24 - 29 Ekim 2008, cilt.58, (Özet Bildiri)

45. Large vessel involvement in Behcet's syndrome: A retrospective survery

Melikoglu M., Ugurlu S., Tascilar K., Caglar E., Seyahi E., Hamuryudan V., et al.

46. Alternative treatments in colchicine-resistant patients with familial mediterranean fever (FMF).

Seyahi E., Ozdogan H., Yazici H.

70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54, (Özet Bildiri)

47. Differences in the frequency of 52kDa and 60kDa anti-SSA/Ro antibodies among primary Sjögren’s Syndrome. Systemic Lupus Eryhematosus and Systemic Lupus Erythematosus with secondary Sjögren’s Syndrome

ÖZBAKIR F., FRESKO İ., SEYAHİ E., Masatlıoğlu S., YAZICI H.

Twelfth International Congress of Histochemistry and Cytochemistry meeting jointly with The Histochemical Society ICHC 2004, San Diago, Amerika Birleşik Devletleri, 24 - 28 Temmuz 2004, cilt.12, ss.3, (Özet Bildiri)

48. Primer Sjögren Sendromu, Sistemik Lupus Eritematosus ve Sistemik Lupus ve Sekonder Sjögren Sendromunda 52kDa-60kDa Anti-SSA/Ro otoantikorları

ÖZBAKIR F., Masatıoğlu U. S., SEYAHİ E., Akgün N., FRESKO İ.

8.Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.165, (Tam Metin Bildiri)

Metrikler

Yayın

251

Yayın (WoS)

224

Yayın (Scopus)

180

Atıf (WoS)

3467

H-İndeks (WoS)

Atıf (Scopus)

4627

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler